Can liver damage from systemic mastocytosis be treated?
Liver damage from systemic mastocytosis, including mast cell leukemia, can potentially be managed, though it depends on the severity and how well the underlying condition responds to treatment.
Graft-versus-host disease (GVHD), which can occur after stem cell Show Full Answer
Can liver damage from systemic mastocytosis be treated?
Liver damage from systemic mastocytosis, including mast cell leukemia, can potentially be managed, though it depends on the severity and how well the underlying condition responds to treatment.
Graft-versus-host disease (GVHD), which can occur after stem cell transplantation for mast cell leukemia, may cause long-term liver damage. Doctors monitor liver function through blood tests and sometimes liver biopsies to assess damage and guide treatment.
Treatment approaches for systemic mastocytosis that may help prevent or reduce organ damage include:
- Targeted therapies like Rydapt (midostaurin), which blocks enzymes that leukemic cells need to grow
- Other kinase inhibitors such as Ayvakit (avapritinib) and Qinlock (ripretinib) for advanced cases
- Chemotherapy with medications like interferon-alpha or cladribine
- Corticosteroids to decrease mast cell levels and relieve symptoms
- Stem cell transplantation for eligible candidates
Early diagnosis and treatment of systemic mastocytosis is important to help prevent severe organ damage. If you're experiencing liver-related symptoms or concerns, discussing monitoring and treatment options with your healthcare team is essential.
March 25
Join
Your Privacy Choices
